Skip to main navigation Skip to search Skip to main content

HPLC determination of phenylpropanolamine in pharmaceutical OTC preparations

Research output: Contribution to journalArticlepeer-review

Abstract

A convenient HPLC method to determine phenylpropanolamine (PPA) in addition to phenylephrine (PE) and chlorpheniramine (CPA) in commercially available over-the-counter (OTC) preparations has been developed. Sample solutions were prepared by dilution with water or methanol followed by filtration and direct injection into the HPLC system. The mobile phase was a mixture of methanol-acetonitrile-acetic acid (0.1 m)-triethylamine (20:20:60:0.6, v/v/v/v) containing sodium heptanesulfonate (0.5 mM) as an ion pair. The separation was achieved on a reversed-phase ODS column with detection wavelength set at 254 nm. The compounds showed good linearity in the range 2.5-1000 μM with detection limits ranged from 0.13 to 0.48 μM. PE, caffeine and CPA were well separated when present together with PPA. The method was applied to the determination of PPA in pharmaceutical preparations including hard and soft capsules.

Original languageEnglish (US)
Pages (from-to)463-469
Number of pages7
JournalBiomedical Chromatography
Volume16
Issue number7
DOIs
StatePublished - Oct 2002
Externally publishedYes

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Molecular Biology
  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Fingerprint

Dive into the research topics of 'HPLC determination of phenylpropanolamine in pharmaceutical OTC preparations'. Together they form a unique fingerprint.

Cite this